Skip Navigation

European Heart Journal 2000 21(13):1063-1071; doi:10.1053/euhj.1999.1856
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sitges, M
Right arrow Articles by Sanz, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sitges, M
Right arrow Articles by Sanz, G
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Feasibility and prognostic value of dobutamine–atropine stress echocardiography early in unstable angina

M Sitges, C Paréf1, M Azqueta, X Bosch, M VelamazáN, J Magriñá and G Sanz

Cardiovascular Institute, Hospital Clínic, University of Barcelona, Spain

revised July 5, 1999; accepted July 27, 1999

Abstract

Background and Aim Because unstable angina has always been considered a contraindication for dobutamine–atropine stress echocardiography (DSE), the role of dobutamine–atropine stress echocardiography in unstable angina is unknown. Our aim was to assess the safety and prognostic value of dobutamine–atropine stress echocardiography in unstable angina.

Methods One hundred and thirty-two patients were studied (mean age 64±12 years, 29 women). Dobutamine–atropine stress echocardiography was performed on the third day after hospital admission. End-points were unstable angina, myocardial infarction or cardiac death at 1 year follow-up.

Results No major complications occurred during dobutamine–atropine stress echocardiography. Ninety-six (78%) patients were on beta-blocker therapy during the test; mean maximum heart rate achieved was 106±23 beats.min–1. Nine of the 21 patients (43%) with a positive dobutamine–atropine stress echocardiography presented cardiac events during follow-up: two patients died, one had a myocardial infarction and six had recurrent class III–IV angina. Among 80 patients with negative dobutamine–atropine stress echocardiography, one (1%) had myocardial infarction and six patients (7·5%) had recurrent angina. Event-free survival after 1 year for patients with a negative dobutamine–atropine stress echocardiography for ischaemia was 91% compared to 57% for those with a positive dobutamine–atropine stress echocardiography (P<0·0001). Left ventricular dysfunction (P=0·01), prior myocardial infarction (P=0·03) and a positive dobutamine–atropine stress echocardiography (P=0·004) were independent predictors of cardiac events during follow-up.

Conclusions Dobutamine–atropine stress echocardiography is safe in unstable angina if it is performed when patients remain asymptomatic for at least 48h. A negative dobutamine–atropine stress echocardiogram for ischaemia predicts a good prognosis in medically treated patients with unstable angina and may allow their early discharge from hospital. Good prognostic information was obtained despite the use of beta-blockers and low heart rates during dobutamine–atropine stress echocardiography.

Key Words: Unstable angina • prognosis • dobutamine stress echocardiography

f1 Correspondence: Carles Paré, Villarroel 170, 08036 Barcelona, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HeartHome page
M Bountioukos, A Elhendy, R T van Domburg, A F L Schinkel, J J Bax, B J Krenning, E Biagini, V Rizzello, M L Simoons, and D Poldermans
Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation
Heart, September 1, 2004; 90(9): 1031 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Pellerin and S.J.D. Brecker
A step further in inter-institutional agreement in interpretation of dobutamine stress echocardiograms
Eur. Heart J., May 2, 2002; 23(10): 768 - 771.
[Full Text] [PDF]


Home page
Eur Heart JHome page
L.A. Pierard
Evaluating risk in unstable angina: role of pharmacological stress echocardiography
Eur. Heart J., July 1, 2000; 21(13): 1041 - 1043.
[PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.